AHA today urged the Antitrust Division of the Department of Justice to investigate thoroughly Centene's proposed acquisition of WellCare “because it threatens to reduce competition in delivery of Medicaid managed care and Medicare Advantage services to tens of millions of consumers across broad swaths of the country.” The letter notes, “There is no service more important to American consumers than health care, and vigorous competition among health insurance companies is necessary to ensure that consumers receive high quality at affordable rates. The facts show that the WellCare-Centene transaction is likely to significantly reduce competition and will therefore harm the most vulnerable Americans. DOJ should vigorously review this transaction's effects on current and future competition and take all appropriate measures to protect U.S. consumers.”

Headline
The AHA commented May 26 to the Federal Trade Commission and the Department of Justice on potential changes to the Hart-Scott-Rodino Antitrust…
Blog
Public
A May 4 guest essay published in The New York Times frames hospitals as the leading “culprit” behind rising health care costs. It reduces a complex health…
Perspective
Public
Just 23 days from now, more than 1,000 hospital and health system leaders from across the country will arrive in Washington, D.C., for the 2026 AHA Annual…
Headline
The AHA March 15 unveiled a new digital ad spotlighting hospitals and health systems as the place where compassion and medicine come together. “There’s …
Headline
The AHA Feb. 24 commended recent remarks made by Federal Trade Commission Chairman Andrew Ferguson on Feb. 20, in which he said the commission should bring…
Headline
The U.S. District Court for the Eastern District of Texas Feb. 12 vacated a final rule by the Federal Trade Commission that changed premerger notification…